Kazuo Miyazaki
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Establishment and Evaluation of Human iPS Cell-Derived Myeloid Cell Lines Susceptible to SARS-CoV-2.
Establishment and Evaluation of Human iPS Cell-Derived Myeloid Cell Lines Susceptible to SARS-CoV-2.
Journal: Microbiology and immunology
Published: July 10, 2025
Rice-derived glucosylceramides activate innate immune responses in myeloid lineage differentiated dendritic cells via toll-like receptors 2 and 4.
Journal: Journal of natural medicines
Published: June 29, 2025
Exploring the Influence of Heat Stress on Gene Expression in Bovine Myeloid Cells In Vitro.
Journal: Animal science journal = Nihon chikusan Gakkaiho
Published: March 07, 2025
IFN-γ derived from activated human CD4+ T cells inhibits the replication of SARS-CoV-2 depending on cell-type and viral strain.
Journal: Scientific reports
Published: August 03, 2024
The First Isolation and Characterization of Bat Jeilongviruses in Japan.
Journal: Transboundary and emerging diseases
Published: July 22, 2024
Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells.
Journal: Scientific reports
Published: January 20, 2023
iPS cell-derived model to study the interaction between tissue macrophage and HIV-1.
Journal: Journal of leukocyte biology
Published: November 08, 2022
Development of a rapid assay system for detecting antibody-dependent enhancement of dengue virus infection.
Journal: Journal of virological methods
Published: July 14, 2022
Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells.
Journal: Scientific reports
Published: May 03, 2022
Dengue virus susceptibility in novel immortalized myeloid cells.
Journal: Heliyon
Published: July 27, 2020
Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers.
Journal: Bioorganic & medicinal chemistry letters
Published: May 30, 2020
Last Updated: 09/26/2026